{
  "report_rows": [
    {
      "kpi": "Diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.92 vs. cons ~$4.94",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales / revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.225B vs. cons ~$1.235B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Tools Group organic sales growth (swing factor)",
      "prediction": "MISS",
      "answer": "pred ~+1.5% vs. cons ~+3.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 organic sales growth outlook / technician confidence tone",
      "prediction": "LOWER",
      "answer": "guide ~+2-3% vs. cons ~+3-4% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Corporate expense run-rate (YoY headwind)",
      "prediction": "LOWER",
      "answer": "guide ~$28M/qtr vs. cons ~$26M (Q2/quarterly 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year effective tax rate",
      "prediction": "UNCHANGED",
      "answer": "guide ~22-23% vs. cons ~22.5% (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Stock enters at all-time highs (+16% YTD, ~2% off record) with insider selling and a rich multiple, so the bar is set for durable Tools/tool-storage recovery. A merely in-line EPS/revenue print with decelerating Tools organic growth and Pinchuk's habitual cautious technician-confidence framing ('not declaring victory') undercuts the priced-in 'green shoots keep flowering' narrative. Out-period math works against the stock: even on an EPS in-line, soft Tools organic + higher corporate expense drive modest downward estimate revisions, so an initial gap-down drifts further over 5 days rather than reversing.",
  "day5_confidence": "LOW"
}